Less Is More: Destiny Phase IIb Trial Population Reduced

Move Agreed With FDA Will Speed Up XF-73 Trial

Bacteria_Staphylococcus
XF-73 is being tested as prevention of post-surgical bacterial infections. • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Anti-infective

More from Therapeutic Category